DHGWA
ORTX

Dixon Hughes Goodman Wealth Advisors’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Dixon Hughes Goodman Wealth Advisors’s Portfolio ORTX Stock Details ORTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$0 Buy
+13
New +$127 ﹤0.01% 1099

Other funds holding ORTX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Dixon Hughes Goodman Wealth Advisors's ORTX Position: Q1 2022 in Review

Dixon Hughes Goodman Wealth Advisors opened a new position in Orchard Therapeutics plc American Depositary Shares (ORTX) in Q1 2022: 13 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #1099 among its holdings.

61 funds tracked by Wall St. Rank hold ORTX as of Q1 2022.

  • Dixon Hughes Goodman Wealth Advisors held 13 shares of Orchard Therapeutics plc American Depositary Shares worth $0 as of Q1 2022.
  • Orchard Therapeutics plc American Depositary Shares was a new Dixon Hughes Goodman Wealth Advisors position in Q1 2022.
  • Orchard Therapeutics plc American Depositary Shares made up ﹤0.01% of Dixon Hughes Goodman Wealth Advisors's portfolio in Q1 2022, its #1099 holding.
  • 61 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q1 2022.

Based on Dixon Hughes Goodman Wealth Advisors's 13F filing for Q1 2022, filed 4 Apr 2022.